The pharmaceutical landscape for glucose is shifting, and transdermal GLP-1 delivery systems represent a exciting advance. Unlike shots, this technique offers a less invasive way to administer GLP-1 therapies. These patches gradually release the treatment through the skin offering a consistent amount of the therapeutic agent, which can optimize blo